Division of Rheumatology, Department of Clinical Medicine, Hospital Universitário Lauro Wanderley, Universidade Federal da Paraíba, João Pessoa, PB, Brazil.
Evidence-Based Health Program, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
PLoS One. 2021 Jun 29;16(6):e0253894. doi: 10.1371/journal.pone.0253894. eCollection 2021.
To describe the laboratory parameters and biomarkers of the cytokine storm syndrome associated with severe and fatal COVID-19 cases.
A search with standardized descriptors and synonyms was performed on November 28th, 2020 of the MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, LILACS, and IBECS to identify studies of interest. Grey literature searches and snowballing techniques were additionally utilized to identify yet-unpublished works and related citations. Two review authors independently screened the retrieved titles and abstracts, selected eligible studies for inclusion, extracted data from the included studies, and then assessed the risk of bias using the Newcastle-Ottawa Scale. Eligible studies were those including laboratory parameters-including serum interleukin-6 levels-from mild, moderate, or severe COVID-19 cases. Laboratory parameters, such as interleukin-6, ferritin, hematology, C-Reactive Protein, procalcitonin, lactate dehydrogenase, aspartate aminotransferase, creatinine, and D-dimer, were extracted from the studies. Meta-analyses were conducted using the laboratory data to estimate mean differences with associated 95% confidence intervals.
The database search yielded 9,620 records; 40 studies (containing a total of 9,542 patients) were included in the final analysis. Twenty-one studies (n = 4,313) assessed laboratory data related to severe COVID-19 cases, eighteen studies (n = 4,681) assessed predictors for fatal COVID-19 cases and one study (n = 548) assessed laboratory biomarkers related to severe and fatal COVID-19 cases. Lymphopenia, thrombocytopenia, and elevated levels of interleukin-6, ferritin, D-dimer, aspartate aminotransferase, C-Reactive-Protein, procalcitonin, creatinine, neutrophils and leucocytes were associated with severe and fatal COVID-19 cases.
This review points to interleukin-6, ferritin, leukocytes, neutrophils, lymphocytes, platelets, C-Reactive Protein, procalcitonin, lactate dehydrogenase, aspartate aminotransferase, creatinine, and D-dimer as important biomarkers of cytokine storm syndrome. Elevated levels of interleukin-6 and hyperferritinemia should be considered as red flags of systemic inflammation and poor prognosis in COVID-19.
描述与严重和致命 COVID-19 病例相关的细胞因子风暴综合征的实验室参数和生物标志物。
于 2020 年 11 月 28 日,使用标准化描述符和同义词,对 MEDLINE、EMBASE、Cochrane 对照试验中心注册库、ClinicalTrials.gov、LILACS 和 IBECS 进行检索,以确定感兴趣的研究。此外,还进行了灰色文献检索和滚雪球技术,以确定尚未发表的工作和相关引文。两名综述作者独立筛选检索到的标题和摘要,选择符合条件的研究进行纳入,从纳入的研究中提取数据,然后使用纽卡斯尔-渥太华量表评估偏倚风险。符合条件的研究是指包括轻度、中度或重度 COVID-19 病例的实验室参数(包括血清白细胞介素-6 水平)的研究。从研究中提取白细胞介素-6、铁蛋白、血液学、C 反应蛋白、降钙素原、乳酸脱氢酶、天冬氨酸氨基转移酶、肌酐和 D-二聚体等实验室参数。使用实验室数据进行荟萃分析,以估计平均值差异及其相关 95%置信区间。
数据库检索产生了 9620 条记录;最终分析纳入了 40 项研究(共 9542 名患者)。21 项研究(n = 4313)评估了与严重 COVID-19 病例相关的实验室数据,18 项研究(n = 4681)评估了致命 COVID-19 病例的预测因素,1 项研究(n = 548)评估了与严重和致命 COVID-19 病例相关的实验室生物标志物。淋巴细胞减少症、血小板减少症以及白细胞介素-6、铁蛋白、D-二聚体、天冬氨酸氨基转移酶、C 反应蛋白、降钙素原、肌酐、中性粒细胞和白细胞升高与严重和致命 COVID-19 病例相关。
本综述指出白细胞介素-6、铁蛋白、白细胞、中性粒细胞、淋巴细胞、血小板、C 反应蛋白、降钙素原、乳酸脱氢酶、天冬氨酸氨基转移酶、肌酐和 D-二聚体是细胞因子风暴综合征的重要生物标志物。白细胞介素-6 和铁蛋白升高应被视为 COVID-19 全身炎症和预后不良的危险信号。